World's Best Scientists 2026 revealed!
Catherine Uyttenhove

Catherine Uyttenhove

D-Index & Metrics

Immunology

D-Index
54
Citations
15569
World Ranking
3845
National Ranking
57

Catherine Uyttenhove publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Catherine Uyttenhove sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 130 publications — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Catherine Uyttenhove D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Catherine Uyttenhove sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Catherine Uyttenhove is affiliated with Ludwig Cancer Research in Belgium. Their research primarily focuses on the biochemical and molecular mechanisms underlying cancer, with significant intersections in immunology and medicine. The scientist's work spans several main fields of study including Biochemistry, Genetics and Molecular Biology, Medicine, and Immunology and Microbiology. They have contributed to subfields such as Molecular Biology, Immunology, Immunology and Allergy, Oncology, and Pulmonary and Respiratory Medicine.

The main topics addressed in their research include:

  • TGF-β signaling in diseases
  • Cell Adhesion Molecules Research
  • Cancer-related gene regulation
  • Cancer Cells and Metastasis
  • T-cell and B-cell Immunology
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction

Their recent publications highlight a focus on immune modulation and cancer therapy strategies. Key papers include:

  • "TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism," 2021, Journal for ImmunoTherapy of Cancer
  • "Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer," 2021, Communications Biology
  • "Novel antibodies that selectively block mouse IL-12 enable the re-evaluation of the role of IL-12 in immune protection and pathology," 2021, European Journal of Immunology
  • "Lactate dehydrogenase-elevating virus enhances natural killer cell-mediated immunosurveillance of mouse mesothelioma development," 2020, Infectious Agents and Cancer
  • "567 Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of stroma poor cancers," 2021, Regular and Young Investigator Award Abstracts

Frequent co-authors in their publications include:

  • Jacques Van Snick
  • Aditi Gupta
  • Sadna Budhu
  • Rachel Giese
  • Adam O. Michel

Their research outputs have appeared across a variety of publication venues such as:

  • Journal for ImmunoTherapy of Cancer
  • Communications Biology
  • European Journal of Immunology
  • Infectious Agents and Cancer
  • Regular and Young Investigator Award Abstracts

Best Publications

  • Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

    Catherine Uyttenhove;Luc Pilotte;Ivan Théate;Ivan Théate;Vincent Stroobant

  • Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset

    Marc Veldhoen;Catherine Uyttenhove;Jacques van Snick;Helena Helmby

  • IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells

    Wassim Elyaman;Elizabeth M. Bradshaw;Catherine Uyttenhove;Valérie Dardalhon

  • Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice

    David Bending;Hugo De La Peña;Marc Veldhoen;Jenny M. Phillips

  • Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase

    Luc Pilotte;Pierre Larrieu;Vincent Stroobant;Didier Colau

  • B cell depletion reduces the development of atherosclerosis in mice

    Hafid Ait-Oufella;Olivier Herbin;Jean-David Bouaziz;Jean-David Bouaziz;Christoph J. Binder

  • Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

    Soraya Taleb;Mélissa Romain;Bhama Ramkhelawon;Catherine Uyttenhove

  • Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity

    C Uyttenhove;R J Simpson;J Van Snick

  • Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9).

    Lothar Hültner;Catherine Druez;Jochen Moeller;Catherine Uyttenhove

  • Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.

    Catherine Uyttenhove;Janet Maryanski;Thierry Boon

  • T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor.

    C Uyttenhove;P G Coulie;J Van Snick

  • Genes coding for tumor-antigens recognized by cytolytic T-lymphocytes

    Aline Van Pel;Pierre Van Der Bruggen;Pierre G. Coulie;Vincent G. Brichard

  • Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes.

    Jingjing Zhu;Jingjing Zhu;Céline G. Powis de Tenbossche;Céline G. Powis de Tenbossche;Stefania Cané;Stefania Cané;Didier Colau;Didier Colau

  • Expression cloning of the murine and human interleukin 9 receptor cDNAs.

    J C Renauld;C Druez;A Kermouni;F Houssiau

  • Blockade of Interleukin-12 Function by Protein Vaccination Attenuates Atherosclerosis

    A.D. Hauer;C. Uyttenhove;P. de Vos;V. Stroobant

  • Cloning and Characterization of a Cdna for a New Mouse T-cell Growth-factor (p40)

    J Van Snick;A Goethals;J C Renauld;E Van Roost

  • A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.

    J B Demoulin;C Uyttenhove;E Van Roost;B DeLestré

  • Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.

    T Boon;J Van Snick;A Van Pel;C Uyttenhove

  • Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis.

    Catherine Uyttenhove;Jacques Van Snick;Jacques Van Snick

  • IL-6 Inhibits the Tolerogenic Function of CD8α+ Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase

    Ursula Grohmann;Francesca Fallarino;Roberta Bianchi;Maria Laura Belladonna

  • Purification and NH2-terminal Amino-acid-sequence of a New T-cell Derived Lymphokine With Growth-factor Activity for B-cell Hybridomas

    Jacques Van Snick;S. Cayphas;A. Vink;Catherine Uyttenhove

Frequent Co-Authors

Jacques Van Snick
Jacques Van Snick Université Catholique de Louvain
Thierry Boon
Thierry Boon Ludwig Cancer Research
Jean-Christophe Renauld
Jean-Christophe Renauld Université Catholique de Louvain
Benoît Van den Eynde
Benoît Van den Eynde Ludwig Cancer Research
J Van Snick
J Van Snick Université Catholique de Louvain
Pierre Coulie
Pierre Coulie Université Catholique de Louvain
Bernhard Ryffel
Bernhard Ryffel University of Orléans
Francesca Fallarino
Francesca Fallarino University of Perugia
Vincent Stroobant
Vincent Stroobant Ludwig Cancer Research
Laure Dumoutier
Laure Dumoutier Université Catholique de Louvain

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many professionals begin their journey with foundational nursing programs. For example, non-nurses in Florida can enroll in online RN programs for non nurses in Florida, which provide a solid clinical background crucial for advanced roles.

Nurse Practitioners (NPs) often pursue specialized tracks to enhance their expertise. Those starting as Family Nurse Practitioners can consider an fnp to acnp bridge program online to transition into acute care, a field closely linked to immunological health crisis management.

Accelerated options, such as the accelerated fnp program, offer a faster route for those aiming to quickly enter clinical practice, making them ideal for motivated students with previous healthcare experience.

Understanding potential earnings is vital when choosing a career path. Resources like the how much do dnps make guide provide insight into salary variations for Doctor of Nursing Practice holders across the U.S., helping students make informed decisions about their education and career.

Best Scientists Citing Catherine Uyttenhove

Trending Scientists

Recently Published Articles